In March 2006, "60 Minutes" reported on a lawsuit against SAC filed by Biovail, a Canadian pharmaceutical company who alleged that SAC had manipulated reports on Biovail in order to drive the price of the stock down.
In March 2006, "60 Minutes" reported on a lawsuit against SAC and Camelback (now known as Gradient Analytics) by Biovail, a Canadian pharmaceutical company. Former Camelback employees alleged that SAC had determined the content and timing of their reports on Biovail in order to drive the price of the stock down.